Stories > Atara Biotherapeutics at Health Conference

Atara Biotherapeutics at Health Conference

AB-2100 Phase 1/2 Trial Initiated

AI-Powered Antigen Research Partnership

Advancements in Cancer Treatment and Mar...

Affini-T Therapeutics at J.P. Morgan Hea...

Anktiva Boosts Lung Cancer Treatment

Breakthrough Bladder Cancer Vaccine Appr...